Small-cap biotech names are gaining attention as clinical readouts and medical conference updates shape market sentiment ...

Both Ironwood Pharmaceuticals IRWD and Puma Biotechnology PBYI are small biotechs, concentrating on the successful commercialization of their respective products with the goal of establishing ...

Biotech ETFs are surging in 2026 as a friendlier FDA, strong M&A activity and AI-driven drug discovery fuel optimism for more ...

Speculative investors and patience rarely go hand in hand. Nevertheless, if you’re looking to invest in the small-cap biotech sector, patience is a requirement. Most, if not all, of these companies ...

Biotech stocks are outperforming the broader market as growth investors return and M&A activity supports valuations across ...

The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points. The index has gained 4.36% ...

Tiziana Life Sciences focuses on immune and inflammatory disease research. Inflammation science remains central to its ...

Biotechnology is among the most volatile sectors in the stock market. Because traditional fundamentals don't apply to a vast majority of biotech stocks -- a function of many of these companies still ...

In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

CorMedix CRMD and Puma Biotechnology PBYI are small-cap biotech companies focused on the successful commercialization of their core products as they work to establish leadership within their ...

CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...

In this piece, we discuss the 10 Best Small-Cap Biotech Stocks to Buy According to Analysts. Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention. This ...